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a b s t r a c t
INTRODUCTION: Non-gestational, extragonadal choriocarcinoma is a rare clinical entity.
PRESENTATIONOF CASE:Herein,we report a 56 year oldwomanwhopresentedwith an incidental adrenal
mass and was diagnosed with a non-gestational choriocarcinoma of the adrenal gland as the sole site of
disease.
DISCUSSION: To our knowledge, this is the ﬁrst case of an ectopic primary adrenal choriocarcinoma. A
metastasis from a primary tumor that completely regressed or that could not be identiﬁed is an alternate
explanation.
CONCLUSION: It should be recognized that choriocarcinoma can affect the adrenal gland and it should be
considered as a rare cause for an adrenal incidentaloma.
© 2014 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
1. Introduction
Choriocarcinoma is a malignant germ cell tumor that occurs in
gonadal and extragonadal sites. Inwomen, choriocarcinoma is clas-
siﬁed into gestational and non-gestational forms. In the gestational
form, choriocarcinoma develops as a result of invasive growth and
erosion of blood vessels in placental tissue, often resulting in hem-
orrhage and necrosis. Choriocarcinoma occurs in approximately 1
in 30,000 pregnancies, two thirds developing after a normal deliv-
ery and one third following a molar gestation.
Non gestational choriocarcinomahas been reported in extrapla-
cental and extragonadal sites. The vast majority represents
systemic metastases, with themost common sites being lung, liver
and brain [1]. Occasionally the primary tumor regresses, leaving
only metastatic lesions to be detected on imaging [2]. Extrago-
nadal choriocarcinomamayoccur as a result of abnormalmigration
of endodermal-derived germ cells along the urogenital ridge and
localization of migrating cells in an ectopic site before reaching the
gonads [3]. Extragonadal sites include thebrain, lungs, stomachand
liver. Herein, we report a case of an adrenal choriocarcinoma.
2. Case presentation
A 56 year old gravida 0, para 0 postmenopausal woman pre-
sented to an Emergency Department with abdominal pain and
bloating. She had known hypertension and hypothyroidism from
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a total thyroidectomy performed for treatment of Graves disease
at age 12. She had no prior history of malignancy and no abdom-
inal surgeries. There was no family history of endocrinopathies.
She smoked one-half of a pack of cigarettes per day for 20 years.
On physical examination her blood pressure and heart rate were
122/72mmHg and 101 beats per minute. Her abdominal examina-
tion was normal.
She had computed tomography of the abdomen and pelvis com-
pleted and was found to have an incidental 4.4 ×3.5×5.3 cm right
adrenal mass (Fig. 1) that was not present on imaging from two
years prior. On a follow-up magnetic resonance imaging study, the
mass was found to have heterogenous signal intensity on both T1
and T2-weighted pulse sequences. There was a 2.3 cm focal area of
hemorrhage, adjacent stranding and edema and no fat component.
The patient was referred to our institution and underwent an
evaluation to exclude a functional adrenal tumor. Physical exami-
nation revealed a normotensive woman in no acute distress with
a body mass index of 28. She had bilateral proptosis. She had a
well-healed scar in her lower neck with no palpable thyroid tis-
sue, no cervicodorsal hump or prominence of the supraclavicular
fat pads. Her abdomen was soft and nontender with no violaceous
striae. She had no bruises and her skin turgor was normal. She
had a normal neurologic examination. Laboratory studies included
serum electrolytes, a 24-h urine collection for metanephrines,
serumaldosterone, plasma renin activity and a 1mgovernight dex-
amethasone suppression test, all of which were normal. She was
diagnosed with a nonfunctioning tumor of the right adrenal gland
that was 5.3 cm in maximum dimension.
Due to the increased riskofmalignancy foradrenal tumors larger
than 4.0 cm, she underwent a laparoscopic right adrenalectomy.
Exploration revealed extensive peritoneal adhesions in the right
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Fig. 1. Computed tomography of right adrenal tumor, A axial, B coronal.
Fig. 2. Hematoxylin and eosin stain of tumor, demonstrating irregular sheets and nests of large undifferentiated trophoblast-like cells admixed with multinucleated
syncytiotrophoblasts (A) and foci of extensive hemorrhage and necrosis (B).
upper quadrant of her abdomen. The mass was conﬁned to the
adrenal gland without local invasion. She recovered well and was
discharged the following day.
Pathologic examination of the specimen demonstrated a
tumor mass measuring 5.0×3.0×7.0 cm with a friable lobulated
yellow–tan cut surface. The tumor was comprised of irregular
sheets and nests of large undifferentiated trophoblast-like cells
admixed with multinucleated syncytiotrophoblasts. Foci of exten-
sive hemorrhage andnecrosiswere present and replaced the native
adrenal architecture (Fig. 2). There was no evidence of local inva-
sion. The tumor cellswerepositive for keratin, epithelialmembrane
antigen, and human choriogonadotropin (hCG). Based on the mor-
phological and immunohistochemical features, the patient was
diagnosed with a choriocarcinoma.
Postoperatively, a gynecologic oncologist further evaluated the
patient. A pelvic exam was normal. Computed tomography of the
chest, abdomen and pelvis revealed a normal uterus and ovaries
with no evidence for additional sites of cancer. Serum -hCG was
7.1mIU/mL. Positron emission tomography in combination with
computed tomography of the chest, abdomen and pelvis showed
no focal area of abnormal metabolic activity. A follow up magnetic
resonance imaging study of the pelvis revealed an incidental uter-
ine leiomyoma and no adnexal masses. Adjuvant chemotherapy
and hysteroscopy with dilation and curettage were recommended,
both of which the patient had declined.
Six months following her initial evaluation for surgery, the
patient presented to the Emergency Department with a three day
history of nausea, dizziness and lightheadedness. She had com-
puted tomography of the head, which showed two new enhancing
cerebellar masses likely representing metastatic disease. Repeat
serum -hCG was 19.8mIU/mL. She followed up with her gyneco-
logic oncologist and after a long discussion, was agreeable towhole
brain radiation. She is currently undergoing radiation and has not
received additional treatment.
3. Discussion
Choriocarcinoma rarely involves the adrenal gland. Our case
is unique in that it may represent an ectopic primary adrenal
choriocarcinoma, which has not been previously reported. It was
a nongestational choriocarcinoma that occurred in a patient who
had never been pregnant. A review of the literature reveals pri-
mary choriocarcinoma reported in extragonadal sites such as the
brain, lungs, stomach and liver, but not in the adrenal gland
[4,5]. Although bilateral adrenal metastases have been reported
in patients with choriocarcinoma [3], the bulk of evidence in our
patient supports that the choriocarcinoma was a primary adrenal
tumor with subsequent development of brain metastases. Alter-
native explanations for the choriocarcinoma in the patient’s right
adrenal gland include a metastasis from a primary tumor that has
not yet been identiﬁed or a primary tumor that has undergone
complete regression.
Treatment of choriocarcinoma includes tumor resection and
systemic chemotherapywithmethotrexate. In patientswith gesta-
tional choriocarcinoma, evacuation of uterine contents by dilation
and curettage is completed. Serial serum hCG levels are monitored
and patients are evaluated for metastatic disease. The 5-year sur-
vival for choriocarcinoma exceeds 85%. Fertility is not impaired;
however, there is a 2% risk of developing trophoblastic disease in
subsequent pregnancies.
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